A Double-blind, Randomized, Multi-center Phase III Clinical Trial to Investigate the Safety and Efficacy Between YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia

Trial Profile

A Double-blind, Randomized, Multi-center Phase III Clinical Trial to Investigate the Safety and Efficacy Between YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Aug 2014

At a glance

  • Drugs Rosuvastatin/telmisartan (Primary) ; Rosuvastatin; Telmisartan
  • Indications Hypercholesterolaemia; Hyperlipidaemia; Hypertension
  • Focus Registrational; Therapeutic Use
  • Sponsors Yuhan
  • Most Recent Events

    • 07 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 15 Jan 2014 Status changed from not yet recruiting to recruiting as reported in ClinicalTrials.gov record.
    • 06 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top